DEVELOPMENT SAFETY UPDATE REPORT - ICH
2.2 Periodicity and DSUR Data Lock Point* The “Development International Birth Date”* (DIBD) is used to determine the start of the annual period for the DSUR. This date is the sponsor’s first authorisation to conduct a clinical trial in any country worldwide. The …
Download DEVELOPMENT SAFETY UPDATE REPORT - ICH
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
PERIODIC BENEFIT-RISK EVALUATION REPORT (PBRER)
database.ich.orgThe Periodic Benefit-Risk Evaluation Report (PBRER) described in this Guideline is intended to be a common standard for periodic benefit-risk evaluation reporting on marketed products (including approved drugs that are under further study) among the ICH regions. This Guideline defines the recommended format and content of a PBRER and provides ...
Report, Evaluation, Risks, Benefits, Periodic, Periodic benefit risk evaluation report, Periodic benefit risk evaluation
ADDENDUM TO ICH E11: CLINICAL INVESTIGATION OF …
database.ich.orgThe number of medicinal products currently labeled for pediatric use is limited. It is the goal of ... ordinarily come from adult human exposure. Repeated dose toxicity studies, reproduction toxicity studies and genotoxicity tests would generally be available. The need for juvenile animal studies
Final Concept Paper ICH Q14: Analytical Procedure ...
database.ich.orgFinal Concept Paper . ICH Q14: Analytical Procedure Development and Revision of Q2(R1) Analytical Validation . dated 14 November 2018 . Endorsed by the Management Committee on 15 November 2018 . Type of Harmonisation Action Proposed It is proposed to develop a new quality guideline on Analytical Procedure Development and
Development, Proposed, Paper, Procedures, Revisions, Analytical, Analytical procedure development and revision
Final Concept Paper ICH Q9(R1) - Quality Risk Management
database.ich.orgFINAL Q9(R1) Concept Paper Endorsed : 13 November 2020 -4- Annex 1: The anticipated benefits of the proposed revision of ICH Q9 The revisions proposed here have the potential to lead to many benefits via increased harmonisation in the use and implementation of QRM, which helps ensure the protection of the patient:
Q12 - ICH
database.ich.orgis endorsed or sponsored by the ICH must be avoided. ... and regulatory authorities by ents, industry ... biopharmaceutical strengthening quality assurance and improving supply of medicinal products. This guideline provides a framework to facilitate the -approval management of …
ICH HARMONISED GUIDELINE
database.ich.org1.5 Approval (in relation to Institutional Review Boards) The affirmative decision of the IRB that the clinical trial has been reviewed and may be conducted at the institution site within the constraints set forth by the IRB, the institution, Good Clinical Practice (GCP), and the applicable regulatory requirements. 1.6 Audit
Good, Practices, Clinical, Good clinical practice, Trail, Relations, In relation
PRECLINICAL SAFETY EVALUATION OF BIOTECHNOLOGY …
database.ich.orgRegulatory standards for biotechnology-derived pharmaceuticals have generally been comparable among the European Union, Japan and United States. All regions have adopted a flexible, case-by-case, science-based approach to preclinical safety evaluation needed to support clinical development and marketing authorisation. In
Evaluation, Regulatory, Safety, Marketing, Biotechnology, Preclinical, Preclinical safety evaluation of biotechnology
Q7 Implementation Working Group ICH Q7 Guideline: Good ...
database.ich.orgDated : 10 June 2015 Q7 Q&As 2 Q7 Questions and Answers 1. INTRODUCTION - SCOPE # Date of Approval Questions Answers 1.1 June 2015 Should GMP according to ICH Q7 be
[ICH E2F] [EXAMPLE DSUR – PHASE III INVESTIGATIONAL …
database.ich.org[EXAMPLE DSUR – PHASE III INVESTIGATIONAL DRUG] ZB3579 Development Safety Update Report #4 Period covered: 1st January 2009 – 31st December 2009 ... • This is the 4th annual DSUR for ZB3579, summarising safety data received by Zoboryn Pharmaceuticals from 1st …
Final Concept Paper ICH Q3E: Guideline for Extractables ...
database.ich.orgdrug indication and patient exposure. The guidance will clarify how prior knowledge may be considered to determine the need for further safety studies. Where additional safety data are needed, a common strategy for obtaining these data will be developed. • Control options: This would include options to mitigate and control process-derived
Related documents
DENTAL MANUAL - manuals.momed.com
manuals.momed.comdental production : 11/01/2021 2 section 1-participant conditions of participation .....18 1.1 individuals eligible for mo healthnet, managed care or state
Mastering Periodic Trends - American Chemical Society
www.acs.orgPerfect your performance with periodicity! Important Trend Terms . Effective nuclear charge: the net positive charge from the nucleus that an electron can “feel” attractions from. The core electrons are said to shield the valence electrons from the full attractive forces of the protons in the nucleus. Shielding:
American, Chemical, Society, American chemical society, Periodicity
SCPS Chemistry Worksheet – Periodicity
www.currituck.k12.nc.usSCPS Chemistry Worksheet – Periodicity - page 4 D. Definitions - match Atomic radius Decrease Electron affinity electronegativity First ionization energy Increase Ionization energy Metals Noble gas configuration Noble gases Nonmetals Semimetal Shielding effect 1. Ionization energy is the energy required to remove an electron from an atom. 2.
European Medicines Agency
www.ema.europa.eu2.2 Periodicity and DSUR Data Lock Point The DSUR is intended to be an annual report that should be submitted to regulatory authorities, as appropriate, for as long as the sponsor conducts clinical trials with the investigational drug, or for as long as appropriate to satisfy local requirements. Where local
European, Agency, Medicine, European medicines agency, Periodicity
THS Med Checkup Periodicity Sched
www.hhs.texas.govTexas Health Steps Medical Checkup Periodicity Schedule for Infants, Children, and Adolescents Author: Texas Health and Human Services Subject: Texas Health Steps Medical Checkup Periodicity Schedule for Infants, Children, and Adolescents Keywords: Texas Health Steps Medical Checkup Periodicity Schedule for Infants, Children, and Adolescents
Maintenance Program Overview - ICAO
www.icao.inttasks are effective and their periodicity is adequate The reliability Program may result in the escalation or deletion of a maintenance tasks, as well as the de- escalation or addition of a maintenance task A reliability Program provides an appropriate means of monitoring the effectiveness of the maintenance Program 37
BAL-005-1 – Balancing Authority Control
www.nerc.comminimum periodicity, accuracy, and availability requirement for acquisition of the data and for providing the information to the System Operator. 4. Applicability: 4.1. Functional Entities: 4.1.1. Balancing Authority . Effective Date: See Implementation Plan for BAL-005-1. B. Requirements and Measures . R1.